Identifying the Risk Factors and Optimal Timing of HCT Myelofibrosis

Track: BMT Tandem "Scientific" Meeting
Saturday, February 14, 2015, 12:30 PM-1:30 PM
Seaport Ballroom DE (Manchester Grand Hyatt)
Vikas Gupta, MD , The Elizabeth and Tony Comper MPN Program, Princess Margaret Cancer Center, Toronto, ON, Canada
Audio File Recorded Presentation
Disclosures:
V. Gupta, Novartis/Incyte, Advisory Board: Honoraria
Novartis, Clinical Study: Research Funding
Novartis, Speaker: Honoraria
See more of: BMT Tandem Saturday Concurrent Luncheon Symposium: Risk Factors and New Methods for Treatment of Myelofibrosis: Transplantation in the Era of JAK Inhibitors
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation >>